Jeffrey Lee, Chief Medical Executive at MD Anderson Cancer Center, shared on LinkedIn:
“It was my pleasure to join the 20th anniversary celebration of the Morgan Welch IBC Research Program and Clinic at UT MD Anderson.
Over the past two decades, the dedication of our faculty, staff, patients, advocates, donors, researchers, clinicians and supporters has helped establish the program as a global leader in inflammatory breast cancer research and care. Their commitment has advanced scientific understanding, accelerated breakthrough research and improved care for patients facing this challenging disease.
Thank you to everyone who has contributed to the success of this program over the past two decades. The progress we recognized would not have been possible without your partnership, advocacy and support. Together, we remain committed to advancing our mission to end cancer and making a meaningful difference in the lives of patients and families affected by inflammatory breast cancer.”
Other articles about UT MD Anderson on OncoDaily.
You can also read: Evelyn H. Lauder at 90: A Legacy That Transformed Breast Cancer Research
